Literature DB >> 17725883

Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS-MS.

June Feng1, Lanqing Wang, Ingrid Dai, Tia Harmon, John T Bernert.   

Abstract

A method was developed for the quantitative analysis of 30 drugs of abuse and their metabolites in urine, including opiates, barbiturates, amphetamines, cocaine, cannabinoids, phencyclidine, methadone, and benzodiazepines. This method uses solid-phase extraction (SPE) on an Oasis HLB column followed by liquid chromatography-tandem mass spectrometry. Analytes were quantified by multiple reaction monitoring with the deuterated analogues as internal standards, using an atmospheric pressure ionization-electrospray interface. The method was validated by examining specificity, precision, accuracy, linearity, recovery, reproducibility, and detection limits. The limits of detection ranged from 9 pg/mL to 2.29 ng/mL in urine depending on the analyte. The SPE procedure was automated on a RapidTrace workstation to increase analytical throughput, and the results obtained via automated SPE were compared to those obtained by manual SPE to examine carryover effect, precision, accuracy, recovery, and reproducibility. To evaluate method performance, 108 urine samples were collected anonymously and tested for the presence of these drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17725883     DOI: 10.1093/jat/31.7.359

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  2 in total

1.  Development and validation of an LC-MS/MS method for determination of phencyclidine in human serum and its application to human drug abuse cases.

Authors:  Krishna C Chimalakonda; Chris Hailey; Ryan Black; Allison Beekman; Rebecca Carlisle; Elizabeth Lowman-Smith; Heathe Singletary; S Michael Owens; Howard Hendrickson
Journal:  Anal Methods       Date:  2010-09-01       Impact factor: 2.896

2.  A high-throughput robotic sample preparation system and HPLC-MS/MS for measuring urinary anatabine, anabasine, nicotine and major nicotine metabolites.

Authors:  Binnian Wei; June Feng; Imran J Rehmani; Sharyn Miller; James E McGuffey; Benjamin C Blount; Lanqing Wang
Journal:  Clin Chim Acta       Date:  2014-06-23       Impact factor: 3.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.